Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
15.12.2021 - Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s abbreviated new drug application (“ANDA”) for vasopressin. This approval follows the ...
Source: wallstreet-online.de